Bristol Myers Squibb · Pharmaceuticals & biotech
AI across biologics and cell-therapy production at BMS Devens
a 42% reduction in New Product Introduction (NPI) time
Case study · Cement, glass & building materials
Phase 2 aimed to turn the kiln models into a working controller that saves energy without hurting clinker quality.
Independently assessed This result was assessed or published by a party other than the manufacturer or its vendor (a World Economic Forum Lighthouse assessment, a government or institute report, or a peer-reviewed paper).
Phase 2 aimed to turn the kiln models into a working controller that saves energy without hurting clinker quality.
Physical and machine-learning kiln and calciner models fed a nonlinear model predictive control advisory system deployed at the Roberta plant.
Percent change as reported by the source; hover for the exact wording
Hybrid physics/ML kiln and calciner models driving nonlinear MPC in advisory mode.
Outcomes as reported by the source. We do not adjust, combine or extrapolate reported figures.
Bristol Myers Squibb · Pharmaceuticals & biotech
a 42% reduction in New Product Introduction (NPI) time
Georgia-Pacific · Paper & packaging
Demonstrated 40% reduction in defoamer usage, improving environmental impact of brownstock washing.
Novelis · Metals & fabrication
53% Scope 3 emissions
Agilent Technologies · Semiconductors & electronics
33% End-to-end cycle time
Put AI to work
Genvo, our implementation partner, works with manufacturers to pick the right first project, connect the systems you already run and put AI agents and tools into daily use, with people approving what goes out.
Assessments and consultations are provided by Genvo. How our partnership works.